Clinical outcomes after switch to mTOR inhibitors in kidney transplant recipients

Introduction: mTOR inhibitors Sirolimus and Everolimus are an alternative for inmunosuppression in renal transplant recipients. The aim of the study was to describe the experience of patients with switch to mTOR inhibitors, followed up for more than five years.Materials and methods: Patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Revista Colombiana de Nefrología
Main Authors: Liliana Mesa-Ramírez, Juan C. Gómez-Vega, Jessica Pino-Escobar, Lina M Rivera, Eliana Manzi-Tarapues, Juan G. Posada-Chávez, Johanna Schweineberg-López, Carlos E. Durán-Rebolledo, Jorge I. Villegas-Otálora, Oscar J. Serrano-Ardila, Luis A. Caicedo-Rusca
Formato: Artigo
Idioma:Inglês
Publicado em: Asociación Colombiana de Nefrología e Hipertensión Arterial 2018
Assuntos:
Medicina
sirolimus
everolimus
immunosuppression
Kidney transplantation
renal insufficiency chronic
Acesso em linha:https://www.redalyc.org/articulo.oa?id=560159496003
https://www.redalyc.org/journal/5601/560159496003/
https://www.redalyc.org/journal/5601/560159496003/html/
https://www.redalyc.org/journal/5601/560159496003/560159496003.epub
https://www.redalyc.org/journal/5601/560159496003/movil
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados